G. Albrand

2.3k total citations · 1 hit paper
44 papers, 1.5k citations indexed

About

G. Albrand is a scholar working on Geriatrics and Gerontology, Physiology and Oncology. According to data from OpenAlex, G. Albrand has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Geriatrics and Gerontology, 17 papers in Physiology and 12 papers in Oncology. Recurrent topics in G. Albrand's work include Frailty in Older Adults (25 papers), Nutrition and Health in Aging (14 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). G. Albrand is often cited by papers focused on Frailty in Older Adults (25 papers), Nutrition and Health in Aging (14 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). G. Albrand collaborates with scholars based in France, Canada and United States. G. Albrand's co-authors include C. Terret, F. Munoz, Elisabeth Sornay‐Rendu, Pierre D. Delmas, F. Duboeuf, Jean Pierre Droz, Gilbert B. Zulian, Pierre Soubeyran, M. Rainfray and Jean‐Pierre Droz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

G. Albrand

40 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study

2014 368 citations Pierre Soubeyran, Carine Bellera et al. profile →

Peers

Countries citing papers authored by G. Albrand

Since Specialization

Citations

This map shows the geographic impact of G. Albrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Albrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Albrand more than expected).

Fields of papers citing papers by G. Albrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Albrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Albrand. The network helps show where G. Albrand may publish in the future.

Co-authorship network of co-authors of G. Albrand

This figure shows the co-authorship network connecting the top 25 collaborators of G. Albrand. A scholar is included among the top collaborators of G. Albrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Albrand. G. Albrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial) 2024 ·BMC Cancer ·(unknown), G. Albrand, (unknown), (unknown), (unknown), Céline Bourgne, Bruno Pereira, (unknown), (unknown), Éric Hermet, Marc Berger	2
2	Treatment guidelines of metastatic colorectal cancer in older patients from the French Society of Geriatric Oncology (SoFOG) 2020 ·Digestive and Liver Disease ·Thomas Aparicio, Florence Canouï‐Poitrine, Philippe Caillet, Éric François, Tristan Cudennec, Élisabeth Carola, G. Albrand, Anne‐Marie Bouvier, Camille R. Petri, (unknown), Jean–Marc Phelip, Leïla Bengrine-Lefèvre, Éléna Paillaud	14
3	Use's assessment of geriatric variables in the older patient with cancer's multidisciplinary team meeting 2019 ·Journal of Geriatric Oncology ·(unknown), (unknown), Matthieu Sarabi, (unknown), (unknown), G. Albrand, C. Terret, Frédérique Rousseau	3
4	Onco-urologie du sujet âgé : aspects épidemiologiques et biologiques 2019 ·Progrès en Urologie ·P. Mongiat-Artus, Éléna Paillaud, G. Albrand, Y. Neuzillet	1
5	Spécificités gériatriques du cancer du rein localisé 2019 ·Progrès en Urologie ·P. Mongiat-Artus, Éléna Paillaud, Philippe Caillet, G. Albrand, Y. Neuzillet	0
6	Évaluation du patient âge présentant un cancer 2019 ·Progrès en Urologie ·P. Mongiat-Artus, Éléna Paillaud, G. Albrand, Philippe Caillet, Y. Neuzillet	2
7	Role of Geriatric Oncologists in Optimizing Care of Urological Oncology Patients 2017 ·European Urology Focus ·Jean‐Pierre Droz, Helen Boyle, G. Albrand, Nicolas Mottet, Martine Puts	17
8	Thérapies ablatives dans le cancer du rein : indications 2017 ·Progrès en Urologie ·Thibault Tricard, Georgia Tsoumakidou, V. Lindner, Julien Garnon, G. Albrand, Xavier Cathelineau, Afshin Gangi, H. Lang	2
9	Impact of comorbidities on the treatment of non-Hodgkin’s lymphoma: a systematic review 2015 ·Expert Review of Hematology ·C. Terret, G. Albrand, M. Rainfray, Pierre Soubeyran	18
10	Challenging treatment decision-making in older urologic cancer patients 2013 ·World Journal of Urology ·Guillaume Ploussard, G. Albrand, François Rozet, Hervé Lang, Éléna Paillaud, P. Mongiat-Artus	23
11	Cancer de la prostate chez les sujets âgés : comment faire le diagnostic, pourquoi et comment mettre en place une évaluation gériatrique 2012 ·Progrès en Urologie ·G. Albrand, Nicolas Mottet, A. Ruffion, Aude Fléchon, René‐Jean Bensadoun, Maddalena Gigante, Laurent Guy, P. Mongiat-Artus	1
12	Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project. 2011 ·Journal of Clinical Oncology ·Pierre Soubeyran, Carine Bellera, (unknown), Damien Heitz, H. Curé, Hubert Rousselot, G. Albrand, V. Servent, O. Saint Jean, Carine Roy, Simone Mathoulin‐Pélissier, M. Rainfray	112
13	Karnofsky Performance Scale (KPS) or Physical Performance Test (PPT)? That is the question 2010 ·Critical Reviews in Oncology/Hematology ·C. Terret, G. Albrand, (unknown), Jean Pierre Droz	57
14	Quality of life in geriatric oncology—An evaluation of standard questionnaires in elderly men with urological malignancies 2010 ·Critical Reviews in Oncology/Hematology ·C. Terret, David Pérol, G. Albrand, Jean Pierre Droz	5
15	L’évaluation gériatrique en cancérologie chez le sujet âgé 2009 ·Progrès en Urologie ·G. Albrand	2
16	Early Breast Cancer in the Elderly 2008 ·Drugs & Aging ·G. Albrand, C. Terret	62
17	Le maniement des médicaments anticancéreux chez les malades âgés 2005 ·La Presse Médicale ·(unknown), G. Albrand, Marc Bonnefoy, P. Courpron, Gilles Freyer	0
18	Geriatric Assessment in Elderly Patients with Prostate Cancer 2004 ·PubMed ·C. Terret, G. Albrand, Jean Pierre Droz	56
19	Are Older French Patients As Willing As Older American Patients to Undertake Chemotherapy? 2003 ·Journal of Clinical Oncology ·Martine Extermann, G. Albrand, Hongbin Chen, Sylvie Zanetta, Ronald S. Schonwetter, Gilbert B. Zulian, Alan Cantor, Jean‐Pierre Droz	108
20	Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: The OFELY Study 2003 ·Bone ·G. Albrand, F. Munoz, Elisabeth Sornay‐Rendu, F. Duboeuf, Pierre D. Delmas	254

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact